APEX: A phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration

Michael N. Cohen, Denis O'Shaughnessy, Kate Fisher, Jennifer Cerami, Carl C. Awh, Daniel E. Salazar, Philip Rosenfeld, Jeffrey S. Heier

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'APEX: A phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences